CARON N J ET AL: "Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 319, no. 1, 18 June 2004 (2004-06-18) , pages 12-20, XP004509842, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2004.04.180 (B1)

DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; September 2002 (2002-09), LI CHENWGWEN ET AL: "Reconstitution of functional human B lymphocytes in NOD/SCID mice engrafted with ex vivo expanded CD34+ cord blood cells", Database accession no. PREV200200550865 & LI CHENWGWEN ET AL: "Reconstitution of functional human B lymphocytes in NOD/SCID mice engrafted with ex vivo expanded CD34+ cord blood cells", EXPERIMENTAL HEMATOLOGY (CHARLOTTESVILLE), vol. 30, no. 9, September 2002 (2002-09), pages 1036-1043, ISSN: 0301-472X (B1)

HABIB, T.: 'Myc stimulates B lymphocyte differentiation and amplifies calcium signaling.' JOURNAL OF CELL BIOLOGY vol. 179, no. 4, 12 November 2007, pages 717 - 731, XP008145169 (B1)

HIRAMATSU, H.: 'Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model.' BLOOD vol. 102, no. 3, 10 April 2003, pages 873 - 880, XP002428078 (B1)

HUANG, C. Y.: 'Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse.' EUROPEAN JOURNAL OF IMMUNOLOGY vol. 38, no. 2, February 2008, pages 342 - 349, XP008145171 (B1)

JU KEVIN L ET AL: "Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo", EXPERIMENTAL NEUROLOGY, vol. 210, no. 2, April 2008 (2008-04), pages 602-607, XP002675944, ISSN: 0014-4886 (B1)

YOUNG, R. M. YOUNG, R. M. ET AL.: 'B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma.' FUTURE ONCOLOGY vol. 4, no. 5, October 2008, pages 591 - 594, XP008145167 (B1)

LITTLEWOOD, T. D.: 'A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.' NUCLEIC ACIDS RESEARCH vol. 23, no. 10, 25 May 1995, pages 1686 - 1690, XP002925103 (B1)

Lei Wu ET AL: "Fusion Protein Vectors to Increase Protein Production and Evaluate the Immunogenicity of Genetic Vaccines", Molecular therapy : the journal of the American Society of Gene Therapy, vol. 2, no. 3, 1 September 2000 (2000-09-01), pages 288-297, XP055473229, US ISSN: 1525-0016, DOI: 10.1006/mthe.2000.0126 (B1)

REFAELI Y ET AL: "The protooncogene MYC can break B cell tolerance", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 102, no. 11, 1 March 2005 (2005-03-01), pages 4097-4102, XP008116683, ISSN: 0027-8424, DOI: 10.1073/PNAS.0409832102 (B1)

REFAELI, Y.: 'The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas.' PLOS BIOLOGY vol. 6, no. 6, 24 June 2008, page E152, XP008145119 (B1)

REFAELI, Y.: 'The protooncogene MYC can break B cell tolerance.' PNAS vol. 102, no. 11, 07 March 2005, pages 4097 - 4102, XP008116683 (B1)

US-B1- 7 311 920 (B1)

LITTLEWOOD T D ET AL: "A MODIFIED OESTROGEN RECEPTOR LIGAND-BINDING DOMAIN AS AN IMPROVED SWITCH FOR THE REGULATION OF HETEROLOGOUS PROTEINS", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 23, no. 10, 1 January 1995 (1995-01-01), pages 1686-1690, XP002925103, ISSN: 0305-1048 (B1)